+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Growth Factors Market by Type (Bone Morphogenetic Proteins, Epidermal Growth Factors, Fibroblast Growth Factors), Product Form (Liquid Formulation, Lyophilized Powder), Source, Purification Grade, Delivery Method, Mode of Action, Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 184 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887523
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Growth Factors Market size was estimated at USD 2.13 billion in 2023, USD 2.27 billion in 2024, and is expected to grow at a CAGR of 7.96% to reach USD 3.64 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Growth Factors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Growth Factors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Growth Factors Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC, Akron Biotech, Applied Biological Materials Inc., Bio-Techne Corporation, Biopharm GmbH, Cell Guidance Systems, Cell Signaling Technology, Inc., Creative Bioarray, F. Hoffmann-La Roche AG, Gemini BioProducts LLC, Johnson & Johnson Services, Inc., Leadgene Biomedical, Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., Miltenyi Biotec B.V. & Co. KG, PeproTech, Inc., Prospec-Tany Technogene Ltd., Proteintech Group, Inc., Repligen Corporation, Reprocell Inc., Rockland Immunochemicals, Inc., Sartorius CellGenix GmbH, Sino Biological, Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Growth Factors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Bone Morphogenetic Proteins
    • Epidermal Growth Factors
    • Fibroblast Growth Factors
    • Hepatocyte Growth Factors
    • Insulin-like Growth Factors
    • Nerve Growth Factors
    • Platelet-Derived Growth Factors
    • Transforming Growth Factors
    • Vascular Endothelial Growth Factors
  • Product Form
    • Liquid Formulation
    • Lyophilized Powder
  • Source
    • Animal-Derived Growth Factors
    • Recombinant Growth Factors
  • Purification Grade
    • Clinical Grade
    • Research Grade
  • Delivery Method
    • Implants
    • Injections
    • Topical Applications
  • Mode of Action
    • Angiogenic Growth Factors
    • Anti-Apoptotic Growth Factors
    • Mitogenic Growth Factors
  • Application
    • Cancer Treatment
    • Cardiovascular Disorders
    • Dental Applications
    • Dermatology
    • Neurological Disorders
    • Ophthalmology
    • Regenerative Medicine
    • Research & Development
    • Wound Healing
  • End-User
    • Biotechnology Companies
    • Cosmetic & Aesthetic Clinics
    • Dental Clinics
    • Hospitals & Clinics
    • Research Institutes & Academic Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Growth Factors Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Growth Factors Market?
  3. What are the technology trends and regulatory frameworks in the Growth Factors Market?
  4. What is the market share of the leading vendors in the Growth Factors Market?
  5. Which modes and strategic moves are suitable for entering the Growth Factors Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Growth Factors Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand from the medical industry and enhanced usage in clinical applications
5.1.1.2. Incorporation of growth factors for regenerative medicine
5.1.2. Restraints
5.1.2.1. High cost of production and complex formulation process
5.1.3. Opportunities
5.1.3.1. Ongoing research and development activities for the development of new growth factors
5.1.3.2. Immobilization of growth factors for cell therapy manufacturing
5.1.4. Challenges
5.1.4.1. Associated side effects and safety concerns
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Growth Factors Market, by Type
6.1. Introduction
6.2. Bone Morphogenetic Proteins
6.3. Epidermal Growth Factors
6.4. Fibroblast Growth Factors
6.5. Hepatocyte Growth Factors
6.6. Insulin-like Growth Factors
6.7. Nerve Growth Factors
6.8. Platelet-Derived Growth Factors
6.9. Transforming Growth Factors
6.10. Vascular Endothelial Growth Factors
7. Growth Factors Market, by Product Form
7.1. Introduction
7.2. Liquid Formulation
7.3. Lyophilized Powder
8. Growth Factors Market, by Source
8.1. Introduction
8.2. Animal-Derived Growth Factors
8.3. Recombinant Growth Factors
9. Growth Factors Market, by Purification Grade
9.1. Introduction
9.2. Clinical Grade
9.3. Research Grade
10. Growth Factors Market, by Delivery Method
10.1. Introduction
10.2. Implants
10.3. Injections
10.4. Topical Applications
11. Growth Factors Market, by Mode of Action
11.1. Introduction
11.2. Angiogenic Growth Factors
11.3. Anti-Apoptotic Growth Factors
11.4. Mitogenic Growth Factors
12. Growth Factors Market, by Application
12.1. Introduction
12.2. Cancer Treatment
12.3. Cardiovascular Disorders
12.4. Dental Applications
12.5. Dermatology
12.6. Neurological Disorders
12.7. Ophthalmology
12.8. Regenerative Medicine
12.9. Research & Development
12.10. Wound Healing
13. Growth Factors Market, by End-User
13.1. Introduction
13.2. Biotechnology Companies
13.3. Cosmetic & Aesthetic Clinics
13.4. Dental Clinics
13.5. Hospitals & Clinics
13.6. Research Institutes & Academic Institutions
14. Americas Growth Factors Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Growth Factors Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Growth Factors Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.2. Market Share Analysis, By Key Player
17.3. Competitive Scenario Analysis, By Key Player
18. Competitive Portfolio
18.1. Key Company Profiles
18.1.1. Abcam PLC
18.1.2. Akron Biotech
18.1.3. Applied Biological Materials Inc.
18.1.4. Bio-Techne Corporation
18.1.5. Biopharm GmbH
18.1.6. Cell Guidance Systems
18.1.7. Cell Signaling Technology, Inc.
18.1.8. Creative Bioarray
18.1.9. F. Hoffmann-La Roche AG
18.1.10. Gemini BioProducts LLC
18.1.11. Johnson & Johnson Services, Inc.
18.1.12. Leadgene Biomedical, Inc.
18.1.13. Lonza Group Ltd.
18.1.14. Merck KGaA
18.1.15. Meridian Bioscience Inc.
18.1.16. Miltenyi Biotec B.V. & Co. KG
18.1.17. PeproTech, Inc.
18.1.18. Prospec-Tany Technogene Ltd.
18.1.19. Proteintech Group, Inc.
18.1.20. Repligen Corporation
18.1.21. Reprocell Inc.
18.1.22. Rockland Immunochemicals, Inc.
18.1.23. Sartorius CellGenix GmbH
18.1.24. Sino Biological, Inc.
18.1.25. Thermo Fisher Scientific Inc.
18.2. Key Product Portfolio
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. GROWTH FACTORS MARKET RESEARCH PROCESS
FIGURE 2. GROWTH FACTORS MARKET SIZE, 2023 VS 2030
FIGURE 3. GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GROWTH FACTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GROWTH FACTORS MARKET DYNAMICS
FIGURE 7. GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GROWTH FACTORS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GROWTH FACTORS MARKET SIZE, BY PRODUCT FORM, 2023 VS 2030 (%)
FIGURE 10. GROWTH FACTORS MARKET SIZE, BY PRODUCT FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 12. GROWTH FACTORS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GROWTH FACTORS MARKET SIZE, BY PURIFICATION GRADE, 2023 VS 2030 (%)
FIGURE 14. GROWTH FACTORS MARKET SIZE, BY PURIFICATION GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2030 (%)
FIGURE 16. GROWTH FACTORS MARKET SIZE, BY DELIVERY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. GROWTH FACTORS MARKET SIZE, BY MODE OF ACTION, 2023 VS 2030 (%)
FIGURE 18. GROWTH FACTORS MARKET SIZE, BY MODE OF ACTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 20. GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. GROWTH FACTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 22. GROWTH FACTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. AMERICAS GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 26. UNITED STATES GROWTH FACTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 31. GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 32. GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned

  • Abcam PLC
  • Akron Biotech
  • Applied Biological Materials Inc.
  • Bio-Techne Corporation
  • Biopharm GmbH
  • Cell Guidance Systems
  • Cell Signaling Technology, Inc.
  • Creative Bioarray
  • F. Hoffmann-La Roche AG
  • Gemini BioProducts LLC
  • Johnson & Johnson Services, Inc.
  • Leadgene Biomedical, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Meridian Bioscience Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • PeproTech, Inc.
  • Prospec-Tany Technogene Ltd.
  • Proteintech Group, Inc.
  • Repligen Corporation
  • Reprocell Inc.
  • Rockland Immunochemicals, Inc.
  • Sartorius CellGenix GmbH
  • Sino Biological, Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information